Evaluating COVID-19 Impact: Non-opioid Pain Patches Witness a Drop in Sales, as Industry De-prioritizes Non-emergency Medical Procedures – Future Market Insights

DUBAI / ACCESSWIRE / June 3, 2020 / Future Market Insights Increasing adoption of non-addictive pain therapeutic solutions and favorable government initiatives are the primary factors fueling adoption of non-opioid pain patches. Backed by government support, prominent market players in non-opioid pain patches landscape are significantly investing in R&D of novel drugs, thereby further boosting the market revenues. As indicated by a market study by Future Market Insights (FMI), the global non-opioid pain patches market will surpass the valuation of US$ 4 Bn during 2020-2029.

However, the sales are likely to witness a drop in the immediate future owing to the unforeseen outbreak of COVID-19. The pandemic has compelled several national governments across the world to impose lockdowns, resulting in the disruption of the medical supply chain and a hindrance to production. Healthcare institutions in North America, Asia, and Europe have deprioritized non-essential medical treatments and associated patient visits. Owing to this factor, the downtrend of the non-opioid pain patches market will persist through the pandemic.

Download a Sample Report with Table of Contents and Figures: https://www.futuremarketinsights.com/reports/sample/rep-gb-11286

Segmental Highlights

Lidocaine patches segment is projected to hold the lion’s share, accounting for nearly 2/3rds of the overall market value owing to the product’s benefits such as superior topical effectiveness, minimal side effects, and prolong transdermal drug release

Hospital pharmacies, retail pharmacies, and drug stores will collectively account for 70% of global market value, with hospital pharmacies driving the majority of sales owing to frequent patient visits for pain management.

North America is currently the leading regional market for non-opioid pain patches, owing to spending on research and development activities and a conducive regulatory environment for non-opioid pain therapeutics.

Europe is forecasted to bestow substantial revenue opportunities for players in the market, backed by an aging population and increasing per capita healthcare expenditure.

Asia Pacific is projected to register higher growth among other regions and will account for the majority of market share by the end of the forecast period. The growth is primarily attributed to the rising incidence of lifestyle-related disorders with a high number of patients suffering from chronic and acute pain.

Analyst’s Viewpoint

“Leading manufacturers in the market are focusing on external development collaboration to innovate novel therapeutics, in a bid to sustain market competition. However, the demand for these products is likely to face decline during the pandemic on the back of changing consumer preferences,” says an FMI analyst.

Request the Coronavirus Impact Analysis across Industries and Markets@ https://www.futuremarketinsights.com/covid19/rep-gb-11286

Coverage

Products: Lidocaine patches, diclofenac patches, methyl salicylate patches, capsaicin patches, ketoprofen patches, and others

Distribution channels: Hospital pharmacies, retail pharmacies & drug stores, and online pharmacies

Regions: North America, Latin America, Western Europe, Eastern Europe, APEJ, Japan, and MEA

Explore FMI’s Lucid Coverage of Healthcare Landscape

Veterinary Vaccines Market– The veterinary vaccines market study analyses the key trends, innovations, regulatory policies, and key strategies adopted by leading players in this evolving landscape.

Peptide Therapeutics Market– The study analyses the peptide therapeutics market and offers growth opportunities in USD million across 30+ countries in six regions.

Digital Pathology Market– With strong growth through 2029, the digital pathology market is witnessing substantial growth in a market.

About Future Market Insights (FMI)

Future Market Insights (FMI) is a leading provider of market intelligence and consulting services, serving clients in over 150 countries. FMI is headquartered in London, the global financial capital, and has delivery centers in the U.S. and India. FMI’s latest market research reports and industry analysis help businesses navigate challenges and take critical decisions with confidence and clarity amidst breakneck competition.

Contact

Mr. Abhishek Budholiya

Unit No: AU-01-H Gold Tower (AU), Plot No: JLT-PH1-I3A,

Jumeirah Lakes Towers, Dubai,

United Arab Emirates

MARKET ACCESS DMCC Initiative

For Sales Enquiries: sales@futuremarketinsights.com

For Media Enquiries: press@futuremarketinsights.com

Market Report: https://www.futuremarketinsights.com/reports/non-opioid-pain-patches-market

Press Release Source: https://www.futuremarketinsights.com/press-release/non-opioid-pain-patches-market

SOURCE: Future Market Insights

View source version on accesswire.com:
https://www.accesswire.com/592563/Evaluating-COVID-19-Impact-Non-opioid-Pain-Patches-Witness-a-Drop-in-Sales-as-Industry-De-prioritizes-Non-emergency-Medical-Procedures–Future-Market-Insights